| Quality indicators . | Brief description . | Definition of denominator . | Definition of numerator . | Total number of patients assessed . | Pooled compliance rate (95% confidence interval) . |
|---|---|---|---|---|---|
| BoM-1 | Choice of radiation schedules | Patients who received radiation therapy for painful BoMa | Patients who received radiation therapy in ≤10 fractions, or for whom the reason for the use of extended-fractionation was written in the medical chart | 435 | 99% (97–100%) |
| BoM-2 | Assessment of pain before radiation therapy | Patients who received radiation therapy for painful BoMa | Patients for whom some description on pain before radiation therapy was written in the medical chart | 435 | 97% (94–99%) |
| BoM-3 | Prompt initiation of radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom radiation therapy was initiated on the day of referral to radiation oncology or the next day | 115 | 82% (68–93%) |
| BoM-4 | Concurrent use of steroids with radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom steroids were initiated or increased concurrently with the initiation of radiation therapy | 115 | 32% (18–47%) |
| BrM-1 | Assessment of performance status before radiation therapy | Patients who received radiation therapy for BrM | Patients for whom performance status before radiation therapy was recorded by radiation oncologists in the medical chart or radiology information system | 288 | 92% (82–99%) |
| BrM-2 | Completion of planned radiation therapy | Patients who received whole-brain radiation therapy for BrM | Patients for whom the planned radiation therapy was completed | 215 | 97% (93–99%) |
| BrM-3 | Initiation of radiation therapy without delay | Patients who received whole-brain radiation therapy for BrMc | Patients for whom the radiation therapy was initiated within 10 days from referral to radiation oncology | 201 | 97% (92–99%) |
| Quality indicators . | Brief description . | Definition of denominator . | Definition of numerator . | Total number of patients assessed . | Pooled compliance rate (95% confidence interval) . |
|---|---|---|---|---|---|
| BoM-1 | Choice of radiation schedules | Patients who received radiation therapy for painful BoMa | Patients who received radiation therapy in ≤10 fractions, or for whom the reason for the use of extended-fractionation was written in the medical chart | 435 | 99% (97–100%) |
| BoM-2 | Assessment of pain before radiation therapy | Patients who received radiation therapy for painful BoMa | Patients for whom some description on pain before radiation therapy was written in the medical chart | 435 | 97% (94–99%) |
| BoM-3 | Prompt initiation of radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom radiation therapy was initiated on the day of referral to radiation oncology or the next day | 115 | 82% (68–93%) |
| BoM-4 | Concurrent use of steroids with radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom steroids were initiated or increased concurrently with the initiation of radiation therapy | 115 | 32% (18–47%) |
| BrM-1 | Assessment of performance status before radiation therapy | Patients who received radiation therapy for BrM | Patients for whom performance status before radiation therapy was recorded by radiation oncologists in the medical chart or radiology information system | 288 | 92% (82–99%) |
| BrM-2 | Completion of planned radiation therapy | Patients who received whole-brain radiation therapy for BrM | Patients for whom the planned radiation therapy was completed | 215 | 97% (93–99%) |
| BrM-3 | Initiation of radiation therapy without delay | Patients who received whole-brain radiation therapy for BrMc | Patients for whom the radiation therapy was initiated within 10 days from referral to radiation oncology | 201 | 97% (92–99%) |
BoM, bone metastases; BrM, brain metastases; MSCC, malignant spinal cord compression.
Patients with hematologic tumors should be excluded from the denominators in all the quality indicators.
aPatients who had received radiation therapy or surgery to the same bone metastases should be excluded from the denominator.
bWhen a symptom in the lower extremities, caused by spinal cord compression, was written in the medical chart or referral letter.
cPatients who received intensity modulated whole brain radiotherapy should be excluded from the denominator.
| Quality indicators . | Brief description . | Definition of denominator . | Definition of numerator . | Total number of patients assessed . | Pooled compliance rate (95% confidence interval) . |
|---|---|---|---|---|---|
| BoM-1 | Choice of radiation schedules | Patients who received radiation therapy for painful BoMa | Patients who received radiation therapy in ≤10 fractions, or for whom the reason for the use of extended-fractionation was written in the medical chart | 435 | 99% (97–100%) |
| BoM-2 | Assessment of pain before radiation therapy | Patients who received radiation therapy for painful BoMa | Patients for whom some description on pain before radiation therapy was written in the medical chart | 435 | 97% (94–99%) |
| BoM-3 | Prompt initiation of radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom radiation therapy was initiated on the day of referral to radiation oncology or the next day | 115 | 82% (68–93%) |
| BoM-4 | Concurrent use of steroids with radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom steroids were initiated or increased concurrently with the initiation of radiation therapy | 115 | 32% (18–47%) |
| BrM-1 | Assessment of performance status before radiation therapy | Patients who received radiation therapy for BrM | Patients for whom performance status before radiation therapy was recorded by radiation oncologists in the medical chart or radiology information system | 288 | 92% (82–99%) |
| BrM-2 | Completion of planned radiation therapy | Patients who received whole-brain radiation therapy for BrM | Patients for whom the planned radiation therapy was completed | 215 | 97% (93–99%) |
| BrM-3 | Initiation of radiation therapy without delay | Patients who received whole-brain radiation therapy for BrMc | Patients for whom the radiation therapy was initiated within 10 days from referral to radiation oncology | 201 | 97% (92–99%) |
| Quality indicators . | Brief description . | Definition of denominator . | Definition of numerator . | Total number of patients assessed . | Pooled compliance rate (95% confidence interval) . |
|---|---|---|---|---|---|
| BoM-1 | Choice of radiation schedules | Patients who received radiation therapy for painful BoMa | Patients who received radiation therapy in ≤10 fractions, or for whom the reason for the use of extended-fractionation was written in the medical chart | 435 | 99% (97–100%) |
| BoM-2 | Assessment of pain before radiation therapy | Patients who received radiation therapy for painful BoMa | Patients for whom some description on pain before radiation therapy was written in the medical chart | 435 | 97% (94–99%) |
| BoM-3 | Prompt initiation of radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom radiation therapy was initiated on the day of referral to radiation oncology or the next day | 115 | 82% (68–93%) |
| BoM-4 | Concurrent use of steroids with radiation therapy for clinical MSCC | Patients who received radiation therapy for clinical MSCCb | Patients for whom steroids were initiated or increased concurrently with the initiation of radiation therapy | 115 | 32% (18–47%) |
| BrM-1 | Assessment of performance status before radiation therapy | Patients who received radiation therapy for BrM | Patients for whom performance status before radiation therapy was recorded by radiation oncologists in the medical chart or radiology information system | 288 | 92% (82–99%) |
| BrM-2 | Completion of planned radiation therapy | Patients who received whole-brain radiation therapy for BrM | Patients for whom the planned radiation therapy was completed | 215 | 97% (93–99%) |
| BrM-3 | Initiation of radiation therapy without delay | Patients who received whole-brain radiation therapy for BrMc | Patients for whom the radiation therapy was initiated within 10 days from referral to radiation oncology | 201 | 97% (92–99%) |
BoM, bone metastases; BrM, brain metastases; MSCC, malignant spinal cord compression.
Patients with hematologic tumors should be excluded from the denominators in all the quality indicators.
aPatients who had received radiation therapy or surgery to the same bone metastases should be excluded from the denominator.
bWhen a symptom in the lower extremities, caused by spinal cord compression, was written in the medical chart or referral letter.
cPatients who received intensity modulated whole brain radiotherapy should be excluded from the denominator.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
